Clinical Trial Update: External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating external-beam radiation therapy, capecitabine, and sorafenib in locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• External beam radiation therapy
• Sorafenib (Sorafenib)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED